JOANNEUM RESEARCH is your dedicated boutique CRO for research projects and drug development programs.

We support your clinical and preclinical activities in the fields of diabetes, dermatology and metabolic research by providing customized bioanalyses, data management and statistical services.


Our Services

We are a full service Contract Research Organization for clinical and preclinical studies together with the Clinical Trial Unit and the Biomedical Research Facility at the Medical University of Graz >.

Data Management

Comprehensive data management services tailored to your clinical and preclinical studies.

Read more

Electronic Data Capture (EDC)

Fully validated online system to capture case report forms (CRFs).

Read more


Cost-effective study design and meaningful data by well-designed and thoroughly analyzed studies.

Read more

Open flow microperfusion

(Pre)clinical PK/PD/BE studies at the target tissue level using our proprietary OFM technology

Read more


High resolution, low volume and high-throughput bioanalysis for clinical and preclinical studies.

Read more


Customer-oriented services in the field of metabolomics and metabolic research

Read more

Data Visualization

Better interpretation of study results for comprehensive insight into your data by graphical data visualization.

Read more

In Vitro Release Testing (IVRT)

Fast and reliable drug release testing by using vitro release testing (IVRT)

Read more

Medical Writing

Professional support in reporting and publishing the results of preclinical and clinical studies.

Read more

Why Us?

We are dedicated to find the best and most cost-effective solution for each individual study.

Latest News

Study results on a short-acting Insulin published



In a cooperative contract research project, HEALTH and Med Uni Graz have tested a new insulin in a clinical phase 1 study on behalf of Arecor. The study, in which HEALTH was responsible for insulin analysis, statistical evaluation, clinical data management, and quality management, showed that the new insulin enters the bloodstream more quickly and thus also acts faster. As a result, blood glucose control in type 1 diabetics is optimized and dangerous hyper- and hypoglycemia can be avoided. The study results are now published in the top-ranking Journal Diabetes Care.

This new type of fast-acting insulin is an important step in the development of an artificial pancreas. HEALTH is proud to support our clients with new developments to further improve the lives of people with diabetes.

Further reading:

Link to paper in Diabetes Care
Our Service Portfolio
Link to Arecor
Link to Medical University of Graz

Our Clients

We work not only with large but also with small to medium-sized pharmaceutical, biotech and medtech companies and start-ups as well as universities.

Our Funding Agencies

Contact Us


HEALTH – Institute for
Biomedicine and Health Sciences

Neue Stiftingtalstrasse 2/Entrance A/Third Floor
8010 Graz

Phone: +43 316 876-4000
Fax: +43 316 8769-4000